Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florian A Distler

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Journal of Cancer Research and Clinical Oncology|June 21, 2022
What would one of the greatest natural scientists and educators of the eighteenth century, Georg Christoph Lichtenberg, say about the current therapy management of patients with penile cancer?Florian A Distler, Sascha Pahernik, Christian Gilfrich, et al.
Urologia Internationalis|October 25, 2022
Impact of Stone Localization before Emergency Ureteral Stenting on Further Stone TreatmentClemens Huettenbrink, Valentin Popeneciu, Jascha Ell, et al.
Urologia Internationalis|February 1, 2022
Salvage Radiotherapy for Recurrent Prostate Cancer after High-Intensity Focused Ultrasound Therapy: Quality of Life and Functional OutcomeBarbara Cafuta, Florian A Distler, Annette Wagner, et al.
Urologia Internationalis|September 18, 2021
A Forgotten Ureteral Stent: Potential Risks for the Urinary FunctionFlorian A Distler, Roland Veelken, Annette Wagner, et al.
World Journal of Urology|June 25, 2021
External validation of two MRI-based risk calculators in prostate cancer diagnosisAnna-Lena Petersmann, Sebastiaan Remmers, Tilman Klein, et al.
The Journal of Urology|April 5, 2017
The Value of PSA Density in Combination with PI-RADS™ for the Accuracy of Prostate Cancer PredictionFlorian A Distler, Jan P Radtke, David Bonekamp, et al.
Cancers|July 27, 2022
The Diagnostic Value of the Added MR Imaging of the Scrotum in the Preoperative Workup of Sonographically Indeterminate Testicular Lesions-A Retrospective Multicenter AnalysisSusanne Deininger, Lukas Lusuardi, Maximilian Pallauf, et al.
Oncotarget|June 2, 2018
Survival outcomes of patients with germ cell tumors treated with high-dose chemotherapy for refractory or relapsing diseaseStefanie Zschäbitz, Florian A Distler, Benjamin Krieger, et al.
Oncotarget|February 5, 2019
Clinical characteristics, treatment outcomes and potential novel therapeutic options for patients with neuroendocrine carcinoma of the prostateLeonidas Apostolidis, Cathleen Nientiedt, Eva Caroline Winkler, et al.
Urologia Internationalis|November 6, 2023
Patient Benefits of Radical Prostatectomy in Certified Prostate Cancer Centers: Comparative Results from the Multicenter IMPROVE StudyDanijel Sikic, Christian Fiebig, Bernd Wullich, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Journal of Cancer Research and Clinical Oncology|June 21, 2022
What would one of the greatest natural scientists and educators of the eighteenth century, Georg Christoph Lichtenberg, say about the current therapy management of patients with penile cancer?Florian A Distler, Sascha Pahernik, Christian Gilfrich, et al.
Urologia Internationalis|October 25, 2022
Impact of Stone Localization before Emergency Ureteral Stenting on Further Stone TreatmentClemens Huettenbrink, Valentin Popeneciu, Jascha Ell, et al.
Urologia Internationalis|February 1, 2022
Salvage Radiotherapy for Recurrent Prostate Cancer after High-Intensity Focused Ultrasound Therapy: Quality of Life and Functional OutcomeBarbara Cafuta, Florian A Distler, Annette Wagner, et al.
Urologia Internationalis|September 18, 2021
A Forgotten Ureteral Stent: Potential Risks for the Urinary FunctionFlorian A Distler, Roland Veelken, Annette Wagner, et al.
World Journal of Urology|June 25, 2021
External validation of two MRI-based risk calculators in prostate cancer diagnosisAnna-Lena Petersmann, Sebastiaan Remmers, Tilman Klein, et al.
The Journal of Urology|April 5, 2017
The Value of PSA Density in Combination with PI-RADS™ for the Accuracy of Prostate Cancer PredictionFlorian A Distler, Jan P Radtke, David Bonekamp, et al.
Cancers|July 27, 2022
The Diagnostic Value of the Added MR Imaging of the Scrotum in the Preoperative Workup of Sonographically Indeterminate Testicular Lesions-A Retrospective Multicenter AnalysisSusanne Deininger, Lukas Lusuardi, Maximilian Pallauf, et al.
Oncotarget|June 2, 2018
Survival outcomes of patients with germ cell tumors treated with high-dose chemotherapy for refractory or relapsing diseaseStefanie Zschäbitz, Florian A Distler, Benjamin Krieger, et al.
Oncotarget|February 5, 2019
Clinical characteristics, treatment outcomes and potential novel therapeutic options for patients with neuroendocrine carcinoma of the prostateLeonidas Apostolidis, Cathleen Nientiedt, Eva Caroline Winkler, et al.
Urologia Internationalis|November 6, 2023
Patient Benefits of Radical Prostatectomy in Certified Prostate Cancer Centers: Comparative Results from the Multicenter IMPROVE StudyDanijel Sikic, Christian Fiebig, Bernd Wullich, et al.
Pageof 2